View by Specialty

Trending

PC0225Bischoff-Ferrari_Graphic_01_WEB
February 13, 2025
2 min read
Save

Daily omega-3 slows biological aging by almost 4 months

Rheumatoid Arthritis News

SPONSORED CONTENT
February 21, 2025
6 min read
Save
Advances in rheumatoid arthritis pathogenesis ‘nothing short of extraordinary’

Advances in rheumatoid arthritis pathogenesis ‘nothing short of extraordinary’

Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the groundwork that may inform a new generation of therapeutic targets and therapies.

SPONSORED CONTENT
February 19, 2025
2 min read
Save

Cycling JAKi after poor response in rheumatoid arthritis better than switching to bDMARD

Cycling JAKi after poor response in rheumatoid arthritis better than switching to bDMARD

For patients with rheumatoid arthritis and inadequate response to JAK inhibitors, cycling to another JAK inhibitor is a more effective option than switching to a biological disease-modifying antirheumatic drug, according to data.

SPONSORED CONTENT
February 13, 2025
2 min read
Save

Lack of adequate mental health care in inflammatory arthritis ‘needs to be addressed’

Lack of adequate mental health care in inflammatory arthritis ‘needs to be addressed’

Depression and anxiety among patients with inflammatory arthritis is significantly undertreated, with large proportions not receiving minimally adequate care, according to data published in Arthritis Research & Therapy.

Trending

PC0225Bischoff-Ferrari_Graphic_01_WEB
February 13, 2025
2 min read
Save

Daily omega-3 slows biological aging by almost 4 months

SPONSORED CONTENT
February 04, 2025
2 min read
Save

TNF inhibitors do not increase adverse event risk in rheumatoid arthritis-associated ILD

TNF inhibitors do not increase adverse event risk in rheumatoid arthritis-associated ILD

Treatment with TNF inhibitors yielded no differences in outcomes vs. other antirheumatic therapies among U.S. veterans with rheumatoid arthritis-associated interstitial lung disease, according to data published in The Lancet Rheumatology.

SPONSORED CONTENT
January 31, 2025
1 min read
Save

FDA approves third Actemra biosimilar; second available in intravenous, subcutaneous forms

FDA approves third Actemra biosimilar; second available in intravenous, subcutaneous forms

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.

SPONSORED CONTENT
January 30, 2025
4 min read
Save

Rheumatoid refresher: Top news you may have missed for Rheumatoid Awareness Day

Rheumatoid refresher: Top news you may have missed for Rheumatoid Awareness Day

While you wait for the groundhog to make his determination this weekend, take some time to buff up your knowledge of rheumatoid arthritis, a chronic autoimmune disease that affects about 1.5 million people in the United States.

SPONSORED CONTENT
January 24, 2025
2 min read
Save

Anti-inflammatory therapies linked to reduced risk, incidence of Parkinson’s disease

Anti-inflammatory therapies linked to reduced risk, incidence of Parkinson’s disease

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was associated with reduced incidence of Parkinson’s disease, data show.

SPONSORED CONTENT
January 22, 2025
2 min read
Save

Exposure to nitrogen oxides, particulate matter increase risk for autoimmune disease

Exposure to nitrogen oxides, particulate matter increase risk for autoimmune disease

Exposure to various air pollutants, such as PM2.5 and nitrogen oxides, increases the risk for several autoimmune diseases, including psoriasis, lupus and rheumatoid arthritis, according to data published in Scientific Reports.

SPONSORED CONTENT
January 22, 2025
2 min read
Save

Odds of DMARD-free remission in rheumatoid arthritis may depend on biological DMARD use

Odds of DMARD-free remission in rheumatoid arthritis may depend on biological DMARD use

Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with rheumatoid arthritis requiring biological DMARDs, it is possible for those who do not require them, according to data.

SPONSORED CONTENT
January 21, 2025
2 min read
Save

EULAR: Start inflammatory arthritis therapies ‘without delay’ after cancer remission

EULAR: Start inflammatory arthritis therapies ‘without delay’ after cancer remission

Targeted therapies for active inflammatory arthritis should be started “without delay” for patients with cancer in remission, according to new EULAR points to consider published in Annals of the Rheumatic Diseases.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails